Bottom line
Is PAWZ a good fund? The bottom line
PAWZ is a managed large blend ETF from ProShares.
It charges 0.5% — about $50 a year on every $10,000 invested, cheaper than 77% of large blend funds we track.
It returned +0.9% over one year, −4.7% a year over five years (as of Dec 31, 2025, per its prospectus).
With $32.5 million in net assets and 38 holdings, its largest position is IDEXX Laboratories, Inc. (10.2%) and the top 10 make up 70.4% of the portfolio.
What stands out
- Low cost: cheaper than 77% of large blend peers
What to watch
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 70.4% of assets
- Small fund ($32.5 million) — small funds are likelier to close
Updated Nov 19, 2026
What PAWZ invests in
ProShares Pet Care ETF (the Fund) seeks investment results, before fees and expenses, that track the performance of the FactSet Pet Care Index (the Index).
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the Index. The Index is designed to measure the performance of companies that stand to benefit from interest in or resources spent on pet ownership. The Index includes companies in at least one of eight FactSet Revere Business Industry Classification System Sub-Industries (RBICS Sub-Industries) that the index provider has identified as related to the pet ownership value chain, including pharmaceuticals, diagnostics, food and supplies manufacturers, retailers, and other pet care services providers. The eight eligible RBICS Sub-Industries are: (1) internet pet and pet supply retail; (2) pet and pet supply stores; (3) pet food manufacturing; (4) pet supplies manufacturing; (5) veterinary diagnostics; (6) veterinary pharmaceuticals; (7) veterinary product distributors…
From the fund's prospectus (filed Sep 25, 2026).
PAWZ performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PAWZ | +0.9% | −4.7% | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What PAWZ costs
On a $10,000 investment, PAWZ's 0.5% expense ratio costs about $50 a year. The prospectus estimates $628 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
PAWZ top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | IDEXX Laboratories, Inc. | 10.15% |
| 2 | Chewy, Inc. | 9.90% |
| 3 | Freshpet, Inc. | 9.81% |
| 4 | Zoetis, Inc. | 9.46% |
| 5 | Virbac SACA | 7.37% |
| 6 | CVS Group plc | 4.99% |
| 7 | Merck & Co., Inc. | 4.84% |
| 8 | Pets at Home Group plc | 4.71% |
| 9 | Nestle SA | 4.64% |
| 10 | Oil-Dri Corp. of America | 4.50% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 70.4% of the fund. See all top 25 holdings and asset mix →